Stock Spotlight: Orora Limited (ASX:ORA)

This week's Stock Spotlight is ASX-listed Orora Limited.


About Orora Limited.


Orora Limited designs, manufactures, and supplies packaging products and services to the grocery, fast moving consumer goods, and industrial markets in Australia, New Zealand, the United States, and internationally. The company operates through Orora Australasia and Orora North America segments. It also provides glass bottles, aluminum cans, tabs, and ends, closures and caps, boxes and cartons, point-of-purchase displays, packaging equipment, rigid and flexible packaging, and general packaging materials and supplies. In addition, the company purchases, warehouses, sells, and delivers a range of packaging and related materials; sells equipment; manufactures corrugated sheets and boxes; and provides point of purchase retail display solutions and other visual communication services. Further, the company offers printing and signage, research and technology, product sourcing, automation and engineering, design, kitting and fulfilment, logistics, and digital technology services.



Source: Yahoo Finance



Key Stats

Source: Yahoo Finance, ASX. Data as of 29/08/24.


Price Performance

Growth Potential

  • ORA may divest the OPS business, and we estimate the sale price could reach A$1.5 - 1.7bn for OPS. Proceeds could be used to significantly deleverage the balance sheet.
  • Exposure to both developed and emerging markets’ growth.
  • Near-term headwinds should be in the price.
  • Revised strategy to become a specialised, value-added beverage packaging business
  • Bolt-on acquisitions (and associated synergies) provide opportunities to supplement organic growth.
  • Leveraged to a falling AUD/USD.
  • Potential corporate activity (ORA has already received a proposal from Lone Star for $2.55 per share)
  • Capital management (current on-market share buyback plus potential for additional initiatives).

Key Risks


  • Acquisition bid does not proceed and any M&A premium in the share price evaporates.
  • Competitive pressures lead to margin erosion.
  • Input cost pressures which the company is unable to pass on to customers.
  • Deterioration in economic conditions in US, EM and Australia.
  • Emerging markets risk.
  • Adverse movements in AUD/USD.
  • Declining OCC prices.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Speak to an Advisor

September 15, 2026
The AI trade is being forced to rethink the pace of progress. Here is what investors should watch across Nvidia, chips, AI spending, software and adoption.
September 9, 2026
Copper is at a record high, yet the global market still has a surplus. So where is all the copper, and why is it becoming harder to find?
By Lavender Wong September 1, 2026
Sharewise CEO Alex Perry sat down with ausbiz to unpack how the platform approached FY26, a year in which it reported an ASX return of almost 11% and a US return above 32%. The conversation ranged from the AI infrastructure theme to specific names on Perry's radar in resources and quantum computing. Here's a rundown of the key points.
August 31, 2026
Warsh gave markets a framework, not a forecast. What his first Jackson Hole keynote means for inflation, rates, forward guidance and the outlook for equities.
August 26, 2026
Get the latest on Impact Minerals (ASX: IPT), including stock performance, technical analysis, forecasts & key insights. See if IPO supports your goals.
August 26, 2026
Get the latest on Valiant Gold (ASX: VAL) with our share price, technical analysis, forecasts & key insights. See if this ASX gold stock fits your investment goals.
August 26, 2026
Learn about Percheron Therapeutics (ASX: PER). Offering share price, technical analysis, forecasts & insights. See if this ASX biotech stock fits your goals.
August 19, 2026
Brent crude hits US$91 as US-Iran talks stall and Strait of Hormuz disruption persists. What's driving the move and what comes next for oil
August 13, 2026
The RBA holds rates at 4.35% as inflation remains elevated. Here’s what the August decision means for the Australian economy, markets and key sectors.
August 6, 2026
As AI becomes cheaper to deploy, could the next investment winners shift beyond chipmakers? Explore how the AI cost race is redefining future tech leaders.